Kennedy Capital Management, Inc. Standard Biotools Inc. Transaction History

Kennedy Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$4.63 - $12.15 $1.71 Million - $4.48 Million	-369,051 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$11.49 - $14.17 $4,078 - $5,030	355 Added 0.1%	369,051 $4.55 Million
Q1 2019 May 13, 2019	SELL	$8.47 - $14.36 $265,144 - $449,525	-31,304 Reduced 7.83%	368,696 $4.9 Million
Q4 2018 Feb 12, 2019	BUY	$7.18 - $8.83 $2.87 Million - $3.53 Million	400,000 New	400,000 $3.45 Million

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $126M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.